Perspectum Announces American Medical Association Issues Unique Category III CPT® Codes for LiverMultiScan Quantitative Multiparametric MR
January 03, 2021
FDA awards funding to Perspectum and physicians at Massachusetts General Hospital to accelerate development of imaging biomarkers as drug development tools in liver disease
December 14, 2020
Perspectum’s RADIcAL1 trial - addressing the health economic burden of invasive diagnostics for NAFLD and NASH
December 09, 2020
Post-conference Q&A - AASLD: The Digital Liver Meeting Experience
December 02, 2020
Hepatica – new tool informs surgeons about previously undiagnosed background liver disease, helping to improve surgical decision-making in liver cancer care
Perspectum presents new data, addressing key challenges of smart imaging
November 29, 2020
Reversing fatty liver disease; New study in Hong Kong will use state-of-the-art clinical technology to evaluate different weight-loss methods
November 17, 2020
CHRISTUS Shreveport-Bossier Health System and Perspectum Offer New Insights into Liver Health with LiverMultiScan
Perspectum launches new multiorgan imaging offering, Atlas®, for pharma sponsors at The Liver Meeting Digital Experience™ (TLMdX) 2020
November 10, 2020
